A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma. - Rini B; Redman B; Garcia JA; Burris HA 3rd; Li S; Fandi A; Beck R; Jungnelius U; Infante JR (Annals of oncology : official journal of the European Society for Medical Oncology, 2014)